Opportunity Information: Apply for PAR 11 024
Apply for PAR 11 024
- The Agency for Health Care Research and Quality in the health sector is offering a public funding opportunity titled "Advances in Patient Safety through Simulation Research (R18)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.226 Research on Healthcare Costs, Quality and Outcomes.
- This funding opportunity was created on Nov 21, 2013 and posted on Nov 9, 2010.
- Applicants must submit their applications by Nov 22, 2013. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Eligible applicants include: County governments Others (see text field entitled Additional Information on Eligibility for clarification) Private institutions of higher education Native American tribal governments (Federally recognized) City or township governments Public and State controlled institutions of higher education Native American tribal organizations (other than Federally recognized tribal governments) State governments.
- Other Eligible Applicants include the following Eligible Agencies of the Federal Government Indian/Native American Tribal Governments (Other than Federally Recognized).
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The Advances in Patient Safety through Simulation Research (R18) funding opportunity (PAR 11-024) is a discretionary grant program from the Agency for Healthcare Research and Quality (AHRQ) focused on strengthening patient safety by advancing the science and practical use of health care simulation. The core goal is to fund a broad range of projects that develop new simulation approaches or rigorously test and evaluate existing simulation methods in ways that measurably improve the safe delivery of care. AHRQ frames simulation not only as a training tool, but also as a research and improvement platform that can be used to study how care is delivered, where systems break down, and how to prevent errors before they reach real patients.
AHRQ emphasizes that simulation in health care typically involves exposing individuals or teams to realistic clinical situations using tools such as high-fidelity mannequins, task trainers, virtual reality environments, standardized patients (trained actors), and other simulation formats. These approaches allow clinicians to practice decision-making, technical skills, communication, and teamwork under conditions that mirror real clinical pressure, while still maintaining a controlled environment. A central advantage highlighted in the announcement is that simulation creates a safe space to learn and make mistakes without putting patients at risk, making it especially valuable for high-risk procedures, rare emergencies, or complex team-based scenarios where real-world learning opportunities can be unpredictable and potentially harmful.
Beyond education and training, the opportunity also explicitly supports using simulation as a test bed for health care systems and processes. This includes simulating workflows, introducing new technologies or procedures in a simulated setting, and identifying failure modes, latent safety threats, and process vulnerabilities that might not be obvious until a new practice is implemented. In practical terms, that could mean testing how a new device, protocol, electronic health record change, or care pathway affects clinician behavior and team coordination, and then refining it based on what the simulation reveals. AHRQ is signaling interest in projects that treat simulation as a method to proactively detect and mitigate safety risks, rather than only reacting after an adverse event occurs.
The solicitation welcomes applications across a wide range of simulation techniques, clinical settings, provider groups, and patient populations. This openness suggests that proposals could be situated in hospitals, outpatient clinics, emergency services, long-term care, or other care environments, and could focus on different types of clinicians and staff, from physicians and nurses to pharmacists, technicians, trainees, and interdisciplinary teams. It also notes interest in priority populations, varied patient conditions, and diverse threats to safety, indicating that applicants are encouraged to tailor simulation research to real safety problems affecting different communities and clinical contexts.
Funding is provided through the AHRQ Research Demonstration and Dissemination Projects (R18) mechanism. This mechanism is commonly used for applied research that not only tests an intervention but also generates evidence that can support implementation, spread, and practical use in real-world settings. Under this structure, the principal investigator and their sponsoring organization are responsible for designing the project, conducting the work, and delivering the evaluation and dissemination components as proposed. The announcement also specifies that there is no cost-sharing or matching requirement, which lowers financial barriers for eligible applicants.
Eligible applicants are broad and include state governments, county governments, and city or township governments, as well as public and state-controlled institutions of higher education and private institutions of higher education. Native American tribal governments (federally recognized) and tribal organizations (other than federally recognized tribal governments) are also eligible, and the eligibility language additionally references eligible agencies of the federal government. This range of eligible entities is consistent with AHRQ's interest in supporting simulation research that can be conducted and evaluated in many types of organizational settings, including academic, public-sector, and tribal health contexts.
Administratively, the program is listed under CFDA 93.226 (Research on Healthcare Costs, Quality and Outcomes). Key dates in the archived record include a posted date of November 9, 2010, with later administrative record dates and an archived status (archive date December 22, 2013). The original closing date is listed as January 7, 2014, with a current closing date shown as November 22, 2013, reflecting that the opportunity record is no longer active and should be treated as an archived announcement. The full announcement was hosted through the NIH grants guide, reflecting the common practice of AHRQ funding opportunities being distributed via NIH electronic systems, and technical access issues were directed to the NIH Office of Extramural Research (OER) webmaster contact.
Overall, this opportunity is aimed at building practical, evidence-based knowledge on how simulation can reduce harm, prevent errors, improve team performance, and uncover system weaknesses before they affect patients. It encourages projects that do more than run training sessions by expecting applicants to develop, test, and evaluate simulation-driven interventions or process improvements in ways that can be replicated, scaled, and used by health care organizations seeking to improve safety outcomes.
Frequently Asked Questions (FAQs): Advances in Patient Safety through Simulation Research (R18) (PAR 11-024)
1) What is the Advances in Patient Safety through Simulation Research (R18) opportunity?
It is a discretionary grant program from the Agency for Healthcare Research and Quality (AHRQ) focused on strengthening patient safety by advancing the science and practical use of health care simulation. The funding opportunity is titled "Advances in Patient Safety through Simulation Research (R18)" and is identified as PAR 11-024.
2) What is the main goal of this funding opportunity?
The core goal is to fund a broad range of projects that either develop new simulation approaches or rigorously test and evaluate existing simulation methods, specifically in ways that measurably improve the safe delivery of care.
3) How does AHRQ define or frame "simulation" for this program?
AHRQ frames simulation not only as a training tool, but also as a research and improvement platform. Simulation is described as a way to study how care is delivered, identify where systems break down, and prevent errors before they reach real patients.
4) What kinds of simulation tools or formats are included?
The opportunity describes simulation as exposing individuals or teams to realistic clinical situations using methods such as high-fidelity mannequins, task trainers, virtual reality environments, standardized patients (trained actors), and other simulation formats.
5) What makes simulation valuable for patient safety, according to the announcement?
A central advantage highlighted is that simulation creates a safe space to learn and make mistakes without putting patients at risk. This is positioned as especially valuable for high-risk procedures, rare emergencies, or complex team-based scenarios where real-world learning opportunities can be unpredictable and potentially harmful.
6) Is this grant only for education and training simulations?
No. While education and training are part of the context, the opportunity explicitly supports using simulation as a test bed for health care systems and processes, not just as a training modality.
7) What does it mean to use simulation as a "test bed" for systems and processes?
It includes simulating workflows, introducing new technologies or procedures in a simulated setting, and identifying failure modes, latent safety threats, and process vulnerabilities that might not be obvious until changes are implemented in real clinical practice.
8) What are examples of what could be tested in a simulated setting under this program?
The announcement gives practical examples such as testing how a new device, protocol, electronic health record change, or care pathway affects clinician behavior and team coordination, and then refining the intervention based on what the simulation reveals.
9) What types of projects does AHRQ appear most interested in supporting?
AHRQ signals interest in projects that treat simulation as a proactive method to detect and mitigate safety risks, rather than only reacting after an adverse event occurs. Projects are expected to develop, test, and evaluate simulation-driven interventions or process improvements with measurable impact on safe care delivery.
10) Are applicants limited to certain clinical settings?
No. The solicitation welcomes applications across a wide range of clinical settings and suggests proposals could be situated in hospitals, outpatient clinics, emergency services, long-term care, or other care environments.
11) Which provider groups or teams can be the focus of the simulation research?
The opportunity is open to different types of clinicians and staff, including physicians, nurses, pharmacists, technicians, trainees, and interdisciplinary teams.
12) Does the opportunity encourage work with specific patient populations?
Yes. It notes interest in priority populations, varied patient conditions, and diverse threats to safety. This indicates applicants are encouraged to tailor simulation research to real safety problems affecting different communities and clinical contexts.
13) What funding mechanism is used for this opportunity?
Funding is provided through the AHRQ Research Demonstration and Dissemination Projects (R18) mechanism.
14) What does the R18 mechanism imply about the kind of work expected?
The R18 mechanism is described as commonly used for applied research that not only tests an intervention but also generates evidence that can support implementation, spread, and practical use in real-world settings. The principal investigator and sponsoring organization are responsible for designing the project, conducting the work, and delivering evaluation and dissemination components as proposed.
15) Is cost-sharing or matching required?
No. The announcement specifies that there is no cost-sharing or matching requirement.
16) Who is eligible to apply for this grant?
Eligible applicants are broad and include state governments, county governments, and city or township governments; public and state-controlled institutions of higher education; private institutions of higher education; Native American tribal governments (federally recognized); tribal organizations (other than federally recognized tribal governments); and eligible agencies of the federal government.
17) What is the CFDA number associated with this program?
The program is listed under CFDA 93.226, titled "Research on Healthcare Costs, Quality and Outcomes."
18) Is this funding opportunity still active?
No. The record is described as archived. Key dates show it was posted on November 9, 2010, and the archive date is December 22, 2013. The closing dates shown in the archived record indicate the opportunity record is no longer active and should be treated as an archived announcement.
19) What closing dates are listed in the archived record?
The archived record lists an original closing date of January 7, 2014, and also shows a current closing date of November 22, 2013, reflecting that the opportunity is no longer active.
20) Where was the full announcement hosted and how was it distributed?
The full announcement was hosted through the NIH grants guide, consistent with AHRQ funding opportunities being distributed via NIH electronic systems.
21) Where were technical access issues directed for this opportunity?
Technical access issues were directed to the NIH Office of Extramural Research (OER) webmaster contact, as referenced in the archived record.
22) What outcomes or impacts is this opportunity trying to advance?
The opportunity is aimed at building practical, evidence-based knowledge on how simulation can reduce harm, prevent errors, improve team performance, and uncover system weaknesses before they affect patients. It encourages projects that can be replicated, scaled, and used by health care organizations seeking to improve safety outcomes.
Browse more opportunities from the same category: Health
Next opportunity: Patient Safety and Medical Liability Reform Demonstration Projects (R18)
Previous opportunity: Molecular Genetics of Drug Addiction and Related Co Morbidities (R01)
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PAR 11 024
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (PAR 11 024) also looked into and applied for these:
| Funding Opportunity |
|---|
| Patient Safety and Medical Liability Reform Demonstration Projects (R18) Apply for PAR 11 025 Funding Number: PAR 11 025 Agency: Agency for Health Care Research and Quality Category: Health Funding Amount: Case Dependent |
| Core Violence and Injury Prevention Program (Core VIPP) Apply for CDC RFA CE11 1101 Funding Number: CDC RFA CE11 1101 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $250,000 |
| Orphans and Vulnerable Children OVC Gender Project in Botswana Apply for 674 11 0002 Funding Number: 674 11 0002 Agency: South Africa USAID Pretoria Category: Health Funding Amount: $16,800,000 |
| The Market for Long Term Care Insurance (R01) Apply for RFA RM 11 002 Funding Number: RFA RM 11 002 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Integrating Comparative Effectiveness Research Findings into Care Delivery through Economic Incentives (R21) Apply for RFA RM 11 001 Funding Number: RFA RM 11 001 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| National Dental Practice Based Research Network Limited Competition (U19) Apply for RFA DE 12 002 Funding Number: RFA DE 12 002 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Minority HIV/AIDS Research Initiative (MARI) to Build Capacity in Black and Hispanic Communities and Among Black and Hispanic Researchers to Conduct HIV/AIDS Epidemiologic and Prevention Research Apply for RFA PS 11 003 Funding Number: RFA PS 11 003 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $200,000 |
| Translational Research Centers in Thrombotic and Hemostatic Disorders (TRC THD) (U54) Apply for RFA HL 12 008 Funding Number: RFA HL 12 008 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NIDCR Behavioral or Social Intervention Planning and Pilot Data Grant (R34) Apply for RFA DE 12 001 Funding Number: RFA DE 12 001 Agency: National Institutes of Health Category: Health Funding Amount: $350,000 |
| Translational Tools for Clinical Studies of Mind/Body and Manual Therapy CAM Interventions (R01) Apply for RFA AT 11 003 Funding Number: RFA AT 11 003 Agency: National Institutes of Health Category: Health Funding Amount: $300,000 |
| Functional Genetics, Epigenetics, and Non coding RNAs in Drug Addiction (R01) Apply for PA 11 033 Funding Number: PA 11 033 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Institutional Collaboration Between The Institute Pasteur Of Madagascar And The Centers For Disease Control And Prevention On Malaria And Vector Borne Diseases (U01) Apply for RFA GH 11 003 Funding Number: RFA GH 11 003 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $600,000 |
| Integrative Neuroscience Initiative on Alcoholism (INIA) Consortia (U01) Apply for RFA AA 11 006 Funding Number: RFA AA 11 006 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Integrated Health Social Marketing Program for Mozambique Apply for 656 11 001 Funding Number: 656 11 001 Agency: Mozambique USAID Maputo Category: Health Funding Amount: $20,557,019 |
| Integrative Neuroscience Initiative on Alcoholism (INIA) Consortia Resource and Support Cores (U24) Apply for RFA AA 11 007 Funding Number: RFA AA 11 007 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Social Science Research in Population and Reproductive Health Apply for APS OAA 10 000002 Funding Number: APS OAA 10 000002 Agency: Agency for International Development Category: Health Funding Amount: $5,000,000 |
| Sustainable Leadership, Managment and Governance RFA Apply for SOL OAA 11 000009 Funding Number: SOL OAA 11 000009 Agency: Agency for International Development Category: Health Funding Amount: $200,000,000 |
| Centers for Autism and Developmental Disabilities Research and Epidemiology (CADDRE) Study to Explore Early Development (SEED) II (U01) Apply for RFA DD 11 002 Funding Number: RFA DD 11 002 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $900,000 |
| Pilot Longitudinal Data Collection to inform Public Health Fragile X Syndrome Apply for RFA DD 11 007 Funding Number: RFA DD 11 007 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $550,000 |
| National Institute on Aging Revision Requests for Active Cooperative Agreements (U01) Apply for PAR 11 042 Funding Number: PAR 11 042 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PAR 11 024", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.